Has Benjamin Pinsky received payments from drug or device companies?

Yes. Drug and device makers reported $13,101 in general payments to Benjamin Pinsky across 13 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Benjamin Pinsky did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Benjamin Pinsky come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Benjamin Pinsky

Anatomic Pathology & Clinical Pathology · Stanford, CANPI 1124216643

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $11,788 of the $13,101 with a category attached, or 90.0%. Genmark Diagnostics, Inc. accounts for 78.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $8,220 and has fallen 90.1% since, to $815 in 2025. Among anatomic pathology & clinical pathology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,101in general payments, 2019–2025

Across 13 payments — averaging $1007.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Genmark Diagnostics, Inc.$10K
Cepheid$1K
Beckman Coulter, Inc.$1K
Hologic Sales And Service, LLC$205
Roche Molecular Systems, Inc.$91
Gen-probe, Inc.$71

$660,276in research payments, 2019–2025

Across 13 payments — averaging $50,790 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Abbott$397K
Agilent Technologies, Inc.$163K
Gen-probe, Inc.$100K

What the payments were for

Consulting fees$11,78890%
Speaking & faculty fees$7256%
Travel & lodging$861%
Food & beverage$5024%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Genmark Diagnostics, Inc.	4	$10,220
Cepheid	2	$1,313
Beckman Coulter, Inc.	1	$1,200
Hologic Sales And Service, LLC	3	$205
Roche Molecular Systems, Inc.	1	$91
Gen-probe, Inc.	2	$71

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ePlex$2,000

How this compares

$13,101 in reported general payments places this provider in the 90th percentile of 814 anatomic pathology & clinical pathology providers in California.

See all anatomic pathology & clinical pathology providers in California →

Other anatomic pathology & clinical pathology in Stanford

Hua ShanStanford$295K
Teri LongacreStanford$60K
Gerald BerryStanford$49K
Yasodha NatkunamStanford$38K
Eric YangStanford$34K
Brooke HowittStanford$31K
Sucheta SrivastavaStanford$28K
Siddhartha JaiswalStanford$26K
Serge AlexanianLos Angeles$3.2M
Brian ConeLos Angeles$519K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →